Key points are not available for this paper at this time.
Regulatory CD4 T cells (Treg) control inflammatory reactions to commensal bacteria and opportunist pathogens. Activation of Treg functions during these processes might be mediated by host-derived proinflammatory molecules or directly by bacterial products. We tested the hypothesis that engagement of germline-encoded receptors expressed by Treg participate in the triggering of their function. We report that the subset of CD4 cells known to exert regulatory functions in vivo (CD45RB(low) CD25(+)) selectively express Toll-like receptors (TLR)-4, -5, -7, and -8. Exposure of CD4(+) CD25(+) cells to the TLR-4 ligand lipopolysaccharide (LPS) induces up-regulation of several activation markers and enhances their survival/proliferation. This proliferative response does not require antigen-presenting cells and is augmented by T cell receptor triggering and interleukin 2 stimulation. Most importantly, LPS treatment increases CD4(+) CD25(+) cell suppressor efficiency by 10-fold and reveals suppressive activity in the CD4(+) CD45RB(low) CD25(-) subset that when tested ex-vivo, scores negative. Moreover, LPS-activated Treg efficiently control naive CD4 T cell-dependent wasting disease. These findings provide the first evidence that Treg respond directly to proinflammatory bacterial products, a mechanism that likely contributes to the control of inflammatory responses.
Building similarity graph...
Analyzing shared references across papers
Loading...
Íris Caramalho
Thiago Lopes‐Carvalho
Dominique Ostler
The Journal of Experimental Medicine
Instituto Gulbenkian de Ciência
Building similarity graph...
Analyzing shared references across papers
Loading...
Caramalho et al. (Mon,) studied this question.
www.synapsesocial.com/papers/6a01579a10d6befb25778a59 — DOI: https://doi.org/10.1084/jem.20021633
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: